Trident Texofab Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve un-audited standalone financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Trident Texofab has informed BSE that its Board of Directors will meet on August 12, 2025, at its registered office in Surat. The main agenda is to consider and approve the unaudited standalone financial results for the quarter ended June 30, 2025 (Q1 FY26). Any other business may be taken up with the Chair's permission. The trading window for the company's shares has been closed since July 1, 2025 and will reopen 48 hours after the results are announced on August 12, 2025. No financial figures have been disclosed yet — these will come after the board approves the results.
This is a routine procedural filing ahead of the Q1 FY26 earnings announcement. Investors should watch the August 12 results for actual revenue, profit, and margin trends. The trading window closure means insiders are restricted from trading until results are public.